Molecular classification of IDH-mutant glioblastomas based on gene expression profiles

Por Wu, Fan, Chai, Rui-Chao, Wang, Zhiliang, Liu, Yu-Qing, Zhao, Zheng, Li, Guan-Zhang, Jiang, Hao-Yu
Publicado no Carcinogenesis (2019)

Prognostic power of a lipid metabolism gene panel for diffuse gliomas

Por Wu, Fan, Zhao, Zheng, Chai, Rui‐Chao, Liu, Yu‐Qing, Li, Guan‐Zhang, Jiang, Hao‐Yu, Jiang, Tao
Publicado no J Cell Mol Med (2019)

PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor

Por Wang, Zhi-liang, Li, Guan-zhang, Wang, Qiang-wei, Bao, Zhao-shi, Wang, Zheng, Zhang, Chuan-bao, Jiang, Tao
Publicado no Oncoimmunology (2018)

Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma

Por Wang, Zhi-liang, Wang, Zheng, Li, Guan-zhang, Wang, Qiang-wei, Bao, Zhao-shi, Zhang, Chuan-bao, Jiang, Tao
Publicado no Front Immunol (2019)

Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme

Por Chen, Bao-Shi, Wang, Kuan-Yu, Yu, Shu-Qing, Zhang, Chuan-Bao, Li, Guan-Zhang, Wang, Zhi-Liang, Bao, Zhao-Shi
Publicado no Oncol Lett (2020)

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression

Por Liu, Han-jie, Hu, Hui-min, Li, Guan-zhang, Zhang, Ying, Wu, Fan, Liu, Xiu, Wang, Kuan-yu, Zhang, Chuan-bao, Jiang, Tao
Publicado no Front Cell Dev Biol (2020)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas

Por Chang, Yu-Zhou, Li, Guan-Zhang, Pang, Bo, Zhang, Ke-Nan, Zhang, Xiao-Hui, Wang, Yong-Zhi, Jiang, Zhong-li, Chai, Rui-Chao
Publicado no Front Cell Dev Biol (2020)

ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme

Por Zhao, Zheng, Zhang, Ke-Nan, Chai, Rui-Chao, Wang, Kuan-Yu, Huang, Ruo-Yu, Li, Guan-Zhang, Wang, Yong-Zhi, Chen, Jing, Jiang, Tao
Publicado no Dis Markers (2019)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas

Por Zhao, Zheng, Li, Guan‐Zhang, Liu, Yu‐Qing, Huang, Ruo‐Yu, Wang, Kuan‐Yu, Jiang, Hao‐Yu, Li, Ren‐Peng, Chai, Rui‐Chao, Zhang, Chuan‐Bao, Wu, Fan
Publicado no J Cell Mol Med (2020)

Classification of diffuse lower‐grade glioma based on immunological profiling

Por Wu, Fan, Wang, Zhi‐Liang, Wang, Kuan‐Yu, Li, Guan‐Zhang, Chai, Rui‐Chao, Liu, Yu‐Qing, Jiang, Hao‐Yu, Zhai, You, Feng, Yue‐Mei, Zhao, Zheng, Zhang, Wei
Publicado no Mol Oncol (2020)

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma

Por Chai, Rui-Chao, Li, Yi-Ming, Zhang, Ke-Nan, Chang, Yu-Zhou, Liu, Yu-Qing, Zhao, Zheng, Wang, Zhi-Liang, Chang, Yuan-Hao, Li, Guan-Zhang, Wang, Kuan-Yu, Wu, Fan, Wang, Yong-Zhi
Publicado no JCI Insight (2019)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy

Por Li, Guan-Zhang, Zhang, Ke-Nan, Wang, Zheng, Hu, Hui-Min, Wang, Zhi-Liang, Huang, Ruo-Yu, Jiang, Hao-Yu, Zhai, You, Feng, Yue-Mei, Chang, Yuan-Hao, Li, Ren-Peng, Wu, Fan, Zeng, Fan, Jiang, Tao, Zhang, Wei
Publicado no Onco Targets Ther (2019)